Invention Grant
- Patent Title: Immune modulation with TLR9 agonists for cancer treatment
-
Application No.: US16557630Application Date: 2019-08-30
-
Publication No.: US10772907B2Publication Date: 2020-09-15
- Inventor: Sudhir Agrawal , Daqing Wang , Wayne Jiang
- Applicant: IDERA PHARMACEUTICALS, INC.
- Applicant Address: US PA Exton
- Assignee: IDERA PHARMACEUTICALS, INC.
- Current Assignee: IDERA PHARMACEUTICALS, INC.
- Current Assignee Address: US PA Exton
- Agency: Morgan, Lewis & Bockius LLP
- Main IPC: C07H21/04
- IPC: C07H21/04 ; A61K31/713 ; C07K16/28 ; A61K39/395 ; A61P35/00 ; A61K45/06 ; A61P35/04 ; A61K9/00
Abstract:
The present invention relates to methods for treating a tumor, including a metastatic tumor, with TLR9 agonist in combination with an immune checkpoint inhibitor therapy.
Public/Granted literature
- US20200054663A1 IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT Public/Granted day:2020-02-20
Information query
